1. YI, Yongjin, et al. Impact of metformin on cardiovascular and kidney outcome based on kidney function status in type 2 diabetic patients: a multicentric, retrospective cohort study. Scientific Reports, 2024, 14.1: 2081.
2. YI, Yongjin. Post-hypercapnic alkalosis: A brief review. Electrolytes & Blood Pressure: E & BP, 2023, 21.1: 18.
3. Lee, G. Y., Kim, W. K., No, J. S., Yi, Y., Park, H. C., Jung, J., ... & Song, J. W. Clinical and immunological predictors of hemorrhagic fever with renal syndrome outcome during the early phase. Viruses, 2022, 14(3), 595.
4. YI, YongJin, et al. Association between haemorrhagic fever with renal syndrome and cancers. International Journal of Infectious Diseases, 2021, 113: 127-135.
5. Jung, H. W., Choi, I. Y., Shin, D. W., Han, K., Yoo, J. E., Chun, S., & Yi, Y.. Association between physical performance and incidence of end-stage renal disease in older adults: a national wide cohort study. BMC nephrology, 2021, 22, 1-10.
6. Yi Y, Park H, Jung J. Effectiveness of inactivated hantavirus vaccine on the disease severity of hemorrhagic fever with renal syndrome. Kidney Res Clin Pract. 2018 Dec;37(4):366？72.
7. Kim W-K, No JS, Lee D, Jung J, Park H, Yi Y, et al. Active Targeted Surveillance to Identify Sites of Emergence of Hantavirus. Clin Infect Dis. 2019 Mar;
8. Yi YJ, Kim HJ, Jo SK, Kim SG, Song YR, Chung W, et al. Comparison of the efficacy and safety profile of morning administration of controlled-release simvastatin versus evening administration of immediate-release simvastatin in chronic kidney disease patients with dyslipidemia. Clin Ther. 2014 Aug;36(8):1182？90.
